Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 6.36 MB)

  Published:

  15 December 2021

• Final appraisal determination 1 committee papers (PDF 1.48 MB)

  Published:

  15 December 2021

• Final appraisal determination 2 committee papers (PDF 1.4 MB)

  Published:

  15 December 2021